These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16844377)

  • 1. New spiro-piperidines as 5-HT2B receptor antagonists.
    Bienaymé H; Chêne L; Grisoni S; Grondin A; Kaloun el-B; Poigny S; Rahali H; Tam E
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4830-3. PubMed ID: 16844377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
    Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists.
    Goodacre CJ; Bromidge SM; Clapham D; King FD; Lovell PJ; Allen M; Campbell LP; Holland V; Riley GJ; Starr KR; Trail BK; Wood MD
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4989-93. PubMed ID: 16168649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.
    Shao Y; Anilkumar GN; Carroll CD; Dong G; Hall JW; Hobbs DW; Jiang Y; Jenh CH; Kim SH; Kozlowski JA; McGuinness BF; Rosenblum SB; Schulman I; Shih NY; Shu Y; Wong MK; Yu W; Zawacki LG; Zeng Q
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1527-31. PubMed ID: 21277198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel series of human CCR1 antagonists.
    Xie YF; Sircar I; Lake K; Komandla M; Ligsay K; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Sakurai N; Barbosa M; Jack R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2215-21. PubMed ID: 18329267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted dipiperidine alcohols as potent CCR2 antagonists.
    Xia M; Hou C; Demong D; Pollack S; Pan M; Brackley J; Singer M; Matheis M; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3562-4. PubMed ID: 18487045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines.
    Lapa GB; Byrd GD; Lapa AA; Budygin EA; Childers SR; Jones SR; Harp JJ
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4915-8. PubMed ID: 16165350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties.
    Moss N; Choi Y; Cogan D; Flegg A; Kahrs A; Loke P; Meyn O; Nagaraja R; Napier S; Parker A; Thomas Peterson J; Ramsden P; Sarko C; Skow D; Tomlinson J; Tye H; Whitaker M
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2206-10. PubMed ID: 19307114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor.
    Tran JA; Pontillo J; Arellano M; Fleck BA; Tucci FC; Marinkovic D; Chen CW; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3434-8. PubMed ID: 15950470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.
    Martin RE; Mohr P; Maerki HP; Guba W; Kuratli C; Gavelle O; Binggeli A; Bendels S; Alvarez-Sánchez R; Alker A; Polonchuk L; Christ AD
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6106-13. PubMed ID: 19786348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
    Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists.
    Wang X; Bhatia PA; Daanen JF; Latsaw SP; Rohde J; Kolasa T; Hakeem AA; Matulenko MA; Nakane M; Uchic ME; Miller LN; Chang R; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem; 2005 Aug; 13(15):4667-78. PubMed ID: 15896964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis.
    Guo T; Shao Y; Qian G; Rokosz LL; Stauffer TM; Hunter RC; Babu SD; Gu H; Hobbs DW
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3696-700. PubMed ID: 15978811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinazolindione derivatives as potent 5-HT3A receptor antagonists.
    Lee BH; Choi MJ; Jo MN; Seo HJ; Nah SY; Cho YS; Nam G; Pae AN; Rhim H; Choo H
    Bioorg Med Chem; 2009 Jul; 17(13):4793-6. PubMed ID: 19447040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1.
    Kazmierski WM; Aquino C; Chauder BA; Deanda F; Ferris R; Jones-Hertzog DK; Kenakin T; Koble CS; Watson C; Wheelan P; Yang H; Youngman M
    J Med Chem; 2008 Oct; 51(20):6538-46. PubMed ID: 18811134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
    Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.